2022-08-012023-07-312023-07-31false13536278Scarlet Therapeutics Limited2024-03-1572110iso4217:GBPxbrli:pure135362782022-08-01135362782023-07-31135362782022-08-012023-07-31135362782021-07-28135362782022-07-31135362782021-07-282022-07-3113536278bus:Micro-entities2022-08-012023-07-3113536278bus:AuditExempt-NoAccountantsReport2022-08-012023-07-3113536278bus:FullAccounts2022-08-012023-07-3113536278bus:PrivateLimitedCompanyLtd2022-08-012023-07-3113536278core:WithinOneYear2023-07-3113536278core:AfterOneYear2023-07-3113536278core:WithinOneYear2022-07-3113536278core:AfterOneYear2022-07-3113536278dpl:CostSales2022-08-012023-07-3113536278dpl:AdministrativeExpenses2022-08-012023-07-3113536278dpl:DistributionCosts2022-08-012023-07-3113536278dpl:CostSales2021-07-282022-07-3113536278dpl:AdministrativeExpenses2021-07-282022-07-3113536278dpl:DistributionCosts2021-07-282022-07-3113536278core:WithinOneYear2023-07-3113536278core:AfterOneYear2023-07-3113536278core:WithinOneYear2022-07-3113536278core:AfterOneYear2022-07-3113536278core:WithinOneYear2022-08-012023-07-3113536278core:AfterOneYear2022-08-012023-07-3113536278bus:Director12022-08-012023-07-3113536278bus:Director22022-08-012023-07-3113536278bus:Director32022-08-012023-07-3113536278bus:Director42022-08-012023-07-3113536278bus:Director52022-08-012023-07-31

Scarlet Therapeutics Limited

Registered Number
13536278
(England and Wales)

Unaudited Financial Statements for the Year ended
31 July 2023

Scarlet Therapeutics Limited
Company Information
for the year from 1 August 2022 to 31 July 2023

Directors

DESTECROIX, Harry Stephen, Dr
FRAYNE, Janet, Professor
IRVINE, Alistair Simpson
Toye, Ashley Mark, Professor
WILSON, Andrew David

Registered Address

Science Creates Old Market
Midland Road
Bristol
BS2 0JZ

Registered Number

13536278 (England and Wales)
Scarlet Therapeutics Limited
Statement of Financial Position
31 July 2023

2023
£

2022
£

Fixed Assets108,513-
Current Assets1,319,3353,100
Prepayments and accrued income2,397-
Creditors amounts falling due within one year(188,355)(18,000)
Net current assets (liabilities)1,133,377(14,900)
Total assets less current liabilities1,241,890(14,900)
Accruals and deferred income(22,407)-
Net assets (liabilities)1,219,483(14,900)
Capital and reserves1,219,483(14,900)
The financial statements were approved and authorised for issue by the Board of Directors on 15 March 2024, and are signed on its behalf by:
IRVINE, Alistair Simpson
Director
Registered Company No. 13536278